Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: The Danish Endometrial Cancer Study (DEMCA)

International Journal of Gynecological Cancer

Volumn 21, Issue 7, 2011, Pages 1191-1199

  Bertelsen, Kamma ^a   Ørtoft, Gitte ^b   Hansen, Estrid Stæhr ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

DEMCA; Endometrial cancer; Intermediate risk group overall survival; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; CARCINOMA; CLINICAL TRIAL; ENDOMETRIUM TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NETHERLANDS; POSTOPERATIVE CARE; UNNECESSARY PROCEDURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NETHERLANDS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; UNNECESSARY PROCEDURES; YOUNG ADULT;

EID: 84856071733     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318229264e     Document Type: Article

References (19)

1. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the Results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(suppl 1):S105-S143.
2. The ASTEC/EN.5 Writing Committee on behalf of the ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.
3. The Writing Committee on behalf of the ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125-136.
4. Creutzberg CL, Nout RA, van de Poll-Franse LV, et al. Long-term outcome of the randomized Portec-1 trial and quality of life of the endometrial cancer survivors. Int J Gynecol Cancer. 2009;235, Abstract 358.
5. Alders J, Abeler J, Kolstad P, et al. Postoperative external irradiation and prognosis parameters in stage I endometrial carcinoma: clinical and histopathogenic study of 540 patients. Obstet Gynecol. 1980;56:419-426.
6. Poulsen HK, Jacobsen M, Bertelsen K, et al. Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group. Int J Gynecol Cancer. 1996;6:38-43.
7. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. Int J Gynecol Obstet. 2006;95:s105-s143.
8. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751. (Pubitemid 38251372)
9. Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT) + chemotherapy (CT) in early-stage high-risk endometrial cancer (NSOG-EC-9501/Eortec 55991)). J Clin Oncol. 2007;25:5503.
10. Poulsen. The Danish Endometrial Cancer study (DEMCA). ACTA Oncol. 1989;4:589-593.
11. StataCorp. Stata Statistical Software, Release 9.0. College Station, TX; 2005.
12. Creutzberg CL, Van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial - PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404-1411. (Pubitemid 30215963)
13. Creutzberg CL, van Putten WL, Carla CJ, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol. 2004;22:1234-1241. (Pubitemid 41079837)
14. Rasool N, Fader A, Seamon L, et al. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol. 2010;116:10-14.
15. CreasmanWT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(suppl 8):2035-2041. (Pubitemid 17145924)
16. Hogberg T. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol. 2008;20:463-469.
17. Randall ME, Filiaci V, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006;24:36-44. (Pubitemid 46630491)
18. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer. 2006;95:266-271. (Pubitemid 44187586)
19. Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol. 2008;108:226.